Abstract
Currently available vaccines are safe, but adverse events, such as localized and systemic skin manifestations, are common and usually mild. On rare occasions anaphylaxis can be observed. When allergy to vaccine components, i.e., infectious agents or other potential allergens, is suspected, detailed clinical history is essential to select subjects at risk of subsequent reactions. Procedures for vaccine hypersensitivity diagnosis and management should be followed in order to guarantee safe subsequent administrations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mansoor O, World Health Organization. Regional Office for the Western Pacific. Immunization safety surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization. 3rd ed. Geneva: World Health Organization Press; 2015.
Wood RA, Berger M, Dreskin SC, et al. Hypersensitivity working Group of the Clinical Immunization Safety Assessment (CISA) network. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics. 2008 Sep;122(3):e771–7.
Echeverría-Zudaire LA, Ortigosa-del Castillo L, Alonso-Lebrero E, Álvarez-García FJ, Cortés-Álvarez N, García-Sánchez N, Martorell-Aragonés A. Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components. Allergol Immunopathol (Madr). 2015 May-Jun;43(3):304–25.
Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E, Jenmalm MC, Lau S, Netterlid E, Schwarze J, Sheikh A, Storsaeter J, Skevaki C, Terreehorst I, Zanoni G. Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol. 2017 Nov;28(7):628–40.
Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Resenwasser LJ. International consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016 Sep;9(1):32.
Micheletti F, Peroni D, Piacentini G, Schweiger V, Mirandola R, Chiesa E, Zanoni G. Vaccine allergy evaluation and management at the specialized Green Channel consultation clinic. Clin Exp Allergy. 2012 Jul;42(7):1088–96.
McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016 Mar;137(3):868–78.
Strebel PM, Papania MJ, Gastanaduy PA, Goodson JL. Measles vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Plotkin’s vaccines. 7th ed. Elsevier; 2018. p. 579–618.
Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European academy of allergy and clinical immunology. Allergy. 2014;69:1026–45.
Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130:25–43.
Kemmeren JM, Vermeer-de Bondt PE, van der Maas NA. Discolored leg syndrome after vaccination-descriptive epidemiology. Eur J Pediatr. 2009;168(1):43–50.
Bankova LG, Walter JE, Iyengar SR, Lorenzo ME, Hornick JL, Castells MC. Generalized bullous eruption after routine vaccination in a child with diffuse cutaneous mastocytosis. J Allergy Clin Immunol Pract. 2013 Jan;1(1):94–6.
Allergens in vaccines. Institute for Vaccine Safety, Jonhs Hopkins Bloomberg School of Public Health Baltimore. Updated dec 2018. http://www.vaccinesafety.edu/components-Allergens.htm. Accessed Feb 2019.
Nagao M, Fujisawa T, Ihara T, Kino Y. Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis. J Allergy Clin Immunol. 2016 Mar;137(3):861–7.
Caubet JC, Rudzeviciene O, Gomes E, Terreehorst I, Brockow K, Eigenmann PA. Managing a child with possible allergy to vaccine. Pediatr Allergy Immunol. 2014 Jun;25(4):394–403.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zanoni, G., Migliorini, M. (2022). Vaccines. In: Bircher, A.J., Maibach, H.I., Brockow, K., Barbaud, A. (eds) Cutaneous Drug Hypersensitivity. Springer, Cham. https://doi.org/10.1007/978-3-030-82743-4_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-82743-4_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-82742-7
Online ISBN: 978-3-030-82743-4
eBook Packages: MedicineMedicine (R0)